News
-
-
-
-
-
-
-
-
-
PRESS RELEASE
Evotec announces significant progress in strategic protein degradation collaboration with Bristol Myers Squibb
Evotec SE announces significant progress in strategic protein degradation collaboration with Bristol Myers Squibb, expanding pipeline of molecular glue degraders for unmet medical needs. Performance-based payments totaling US$75 m -
PRESS RELEASE
Record order backlog at the end of Q1/2025 impressively underlines Vossloh's strong performance; positive outlook for 2025 confirmed
Vossloh's record order backlog in Q1/2025 highlights strong performance with orders at €339.2 million and backlog at €926.4 million. Positive 2025 outlook confirmed